Pulseless electrical activity risk factors: Difference between revisions
Mahmoud Sakr (talk | contribs) No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
==Overview== | ==Overview== | ||
The administration of [[beta blockers]] and [[calcium channel blockers]] is associated with an increased risk of PEA. This may be due to their effect on Ca / troponin interactions, and their inhibition of myocardial contractility. | The administration of [[beta blockers]] and [[calcium channel blockers]] is associated with an increased risk of PEA. This may be due to their effect on Ca / troponin interactions, and their inhibition of myocardial contractility. | ||
History of syncope and pulmonary disease is also associated with a higher risk of presenting PEA <ref name="pmid21060069">{{cite journal| author=Teodorescu C, Reinier K, Dervan C, Uy-Evanado A, Samara M, Mariani R et al.| title=Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. | journal=Circulation | year= 2010 | volume= 122 | issue= 21 | pages= 2116-22 | pmid=21060069 | doi=10.1161/CIRCULATIONAHA.110.966333 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21060069 }} </ref>, as well as history of syncope. | |||
==Risk Factors== | |||
===Beta Blockers and Calcium Channel Blockers== | |||
===Syncope and PEA=== | |||
There is a strong correlation between patients that had a syncope episode to present future PEA, than those who didn’t. Prevalence is also higher in patients that presented PEA, than those who presented VF/VT or asystolia. Findings were consistent with an odds ratio of 2.64 (Confidence interval 1.31 to 5.32) versus VF/VT and OR of 2.27 (Confidence interval of 1.08 to 4.78) versus asystolia <ref name="pmid21060069">{{cite journal| author=Teodorescu C, Reinier K, Dervan C, Uy-Evanado A, Samara M, Mariani R et al.| title=Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. | journal=Circulation | year= 2010 | volume= 122 | issue= 21 | pages= 2116-22 | pmid=21060069 | doi=10.1161/CIRCULATIONAHA.110.966333 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21060069 }} </ref>. | |||
===Pulmonary Disease and PEA=== | |||
Teodorescu et al suggest, a strong relation between pulmonary disease and increased frequency of PEA. There are other publications supporting this association <ref name="pmid3988275">{{cite journal| author=Pirolo JS, Hutchins GM, Moore GW| title=Electromechanical dissociation: pathologic explanations in 50 patients. | journal=Hum Pathol | year= 1985 | volume= 16 | issue= 5 | pages= 485-7 | pmid=3988275 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3988275 }} </ref> <ref name="pmid8923578">{{cite journal| author=Herlitz J, Rosenfelt M, Bång A, Axelsson A, Ekström L, Wennerblom B et al.| title=Prognosis among patients with out-of-hospital cardiac arrest judged as being caused by deterioration of obstructive pulmonary disease. | journal=Resuscitation | year= 1996 | volume= 32 | issue= 3 | pages= 177-84 | pmid=8923578 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8923578 }} </ref>. | |||
==References== | ==References== | ||
Revision as of 16:30, 12 December 2013
 |
Resident Survival Guide |
|
Pulseless electrical activity Microchapters |
|
Differentiating Pulseless Electrical Activity from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pulseless electrical activity risk factors On the Web |
|
American Roentgen Ray Society Images of Pulseless electrical activity risk factors |
|
Directions to Hospitals Treating Pulseless electrical activity |
|
Risk calculators and risk factors for Pulseless electrical activity risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The administration of beta blockers and calcium channel blockers is associated with an increased risk of PEA. This may be due to their effect on Ca / troponin interactions, and their inhibition of myocardial contractility. History of syncope and pulmonary disease is also associated with a higher risk of presenting PEA [1], as well as history of syncope.
Risk Factors
=Beta Blockers and Calcium Channel Blockers
Syncope and PEA
There is a strong correlation between patients that had a syncope episode to present future PEA, than those who didn’t. Prevalence is also higher in patients that presented PEA, than those who presented VF/VT or asystolia. Findings were consistent with an odds ratio of 2.64 (Confidence interval 1.31 to 5.32) versus VF/VT and OR of 2.27 (Confidence interval of 1.08 to 4.78) versus asystolia [1].
Pulmonary Disease and PEA
Teodorescu et al suggest, a strong relation between pulmonary disease and increased frequency of PEA. There are other publications supporting this association [2] [3].
References
- ↑ 1.0 1.1 Teodorescu C, Reinier K, Dervan C, Uy-Evanado A, Samara M, Mariani R; et al. (2010). "Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study". Circulation. 122 (21): 2116–22. doi:10.1161/CIRCULATIONAHA.110.966333. PMID 21060069.
- ↑ Pirolo JS, Hutchins GM, Moore GW (1985). "Electromechanical dissociation: pathologic explanations in 50 patients". Hum Pathol. 16 (5): 485–7. PMID 3988275.
- ↑ Herlitz J, Rosenfelt M, Bång A, Axelsson A, Ekström L, Wennerblom B; et al. (1996). "Prognosis among patients with out-of-hospital cardiac arrest judged as being caused by deterioration of obstructive pulmonary disease". Resuscitation. 32 (3): 177–84. PMID 8923578.